Statistics

Total Visits

Views
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study42

Select a period of time:

Number of views in the range

Views
JEVTCC: Phase II trial of cabazitaxel (Cbz) in patients (pt) with advanced or metastatic transitional-cell carcinoma (mTCC), who progressed before 12 months after cisplatin-based chemotherapy-A Spanish Oncologic Genitourinary Group (SOGUG) study19

Views

Views
June 20252
July 202513
August 20250
September 20251
October 20250
November 20251
December 20252
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil7
United States6
Barbados1
United Kingdom1
Paraguay1
Tunisia1
Turkey1
South Africa1
 

Top cities views

Views
Adana1
Alta Floresta1
Asunción1
Avondale1
Buda1
Cape Town1
Cuité1
Dallas1
Jundiaí1
Kasserine1